Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hootan Khatami

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Postgraduate Medicine|November 22, 2014
The biosimilar insulin landscape: current developmentsFernando J Lavalle-González, Hootan Khatami
Diabetes Technology & Therapeutics|March 20, 2015
An Overview of Current Regulatory Requirements for Approval of Biosimilar InsulinsLutz Heinemann, Hootan Khatami, Ross McKinnon, et al.
Diabetes Technology & Therapeutics|January 25, 2017
Administration of Biosimilar Insulin Analogs: Role of DevicesLutz Heinemann, Ingo Fritz, Hootan Khatami, et al.
Plos One|February 27, 2009
Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled studyGiorgos K Sakkas, Kathleen Mulligan, Makani Dasilva, et al.
AIDS Research and Treatment|September 12, 2012
Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected MenMadhu N Rao, Morris Schambelan, Viva W Tai, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemiaKathleen Mulligan, Hootan Khatami, Jean-Marc Schwarz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Postgraduate Medicine|November 22, 2014
The biosimilar insulin landscape: current developmentsFernando J Lavalle-González, Hootan Khatami
Diabetes Technology & Therapeutics|March 20, 2015
An Overview of Current Regulatory Requirements for Approval of Biosimilar InsulinsLutz Heinemann, Hootan Khatami, Ross McKinnon, et al.
Diabetes Technology & Therapeutics|January 25, 2017
Administration of Biosimilar Insulin Analogs: Role of DevicesLutz Heinemann, Ingo Fritz, Hootan Khatami, et al.
Plos One|February 27, 2009
Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled studyGiorgos K Sakkas, Kathleen Mulligan, Makani Dasilva, et al.
AIDS Research and Treatment|September 12, 2012
Assessing the Association between Leptin and Bone Mineral Density in HIV-Infected MenMadhu N Rao, Morris Schambelan, Viva W Tai, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemiaKathleen Mulligan, Hootan Khatami, Jean-Marc Schwarz, et al.
Pageof 1